SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MEDX ... anybody following?
MEDX 31.43-0.7%Nov 7 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Icebrg who wrote (660)4/17/2003 12:15:04 PM
From: Icebrg  Read Replies (1) of 2240
 
OGS announces that Professor Raymond Dwek, Professor Max Burger and Dr Donald Drakeman have resigned from the Board of the Company and that Peter Allen, John Slater Peter Nicholls, Ian Nicholson, Jonathan Glenn and Andrew Weir have been appointed to the Board as non-executive directors, in each case with effect from 17 April 2003.

Peter Allen is a director of Celltech Group plc (“Celltech”), which made a cash offer for the entire issued ordinary share capital of the Company on 1 March 2003.

These changes to the Board reflect the fact that, following posting of the Celltech Offer Document, Celltech holds a controlling interest in the Company.


Comment: Good for DD. Now he will have more time trying to save his own company.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext